Pinnacle SR 8701 Unipolar & 8702 Bipolar
510(k) K870142
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK870142 | Date22 Apr 1987 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Pinnacle SR 8701 Unipolar and 8702 Bipolar are implantable pacemaker pulse-generators, designed to regulate cardiac rhythm by delivering electrical impulses to the heart. These devices are classified as Class III medical devices under FDA regulations, requiring pre-market approval due to their role in managing life-sustaining or life-supporting functions.
These pulse-generators are intended for single-patient use and are implanted within the body, typically in the chest region. They are supplied sterile and require surgical implantation by a healthcare professional, with no indication of MRI compatibility in the specifications. The devices are authorized under FDA 510(k) clearance (K870142) and fall under regulation number 870.3610, ensuring compliance with cardiovascular device standards.
Other devices from Cardio-Pace Medical, Inc.
Questions
AI-generated answers, 18 Sep 2026
Are these pacemakers designed for use in patients who require both unipolar and bipolar pacing options, and how does that affect their clinical application?
The Pinnacle SR models (8701 Unipolar and 8702 Bipolar) are distinct devices tailored for specific pacing configurations. The 8701 Unipolar delivers electrical impulses through a single electrode, while the 8702 Bipolar uses two electrodes, which can reduce muscle stimulation and improve pacing thresholds. Clinicians may choose between them based on patient anatomy, lead placement, or pacing efficiency requirements. Both are intended for single-patient use and implanted surgically in the chest region to regulate cardiac rhythm.
How are these devices supplied, and what precautions should be taken during handling to maintain sterility?
The Pinnacle SR 8701 and 8702 pulse-generators are supplied sterile and intended for single-patient use only. They must be handled using aseptic techniques to prevent contamination before implantation. The sterile packaging should remain intact until the device is ready for surgical use, and any exposed components must be discarded to avoid compromising sterility. These devices are not designed for reuse or reprocessing.
What storage conditions are recommended for these pacemakers before implantation, and are there any special handling instructions?
While specific storage conditions aren’t detailed in the provided data, implantable pulse-generators like the Pinnacle SR typically require protection from extreme temperatures, moisture, and physical damage. They should be stored in their original, sealed packaging in a clean, dry environment until use. Avoid exposure to direct sunlight or magnetic fields, though MRI compatibility is not mentioned, so caution is advised if MRI exposure is anticipated. Always follow manufacturer guidelines if additional storage instructions are provided.
Are there any differences in the regulatory pathway or approval status between the unipolar and bipolar models, and how does that impact their availability?
Both the 8701 Unipolar and 8702 Bipolar models are authorized under the same FDA 510(k) clearance (K870142) and fall under regulation 870.3610, confirming they meet cardiovascular device standards. The regulatory pathway is identical for both, meaning they share the same compliance requirements and approval status. Availability depends on the manufacturer’s distribution channels, but neither model requires separate clearance due to their classification as substantially equivalent devices under the same submission.